We will be exhibiting at the Interphex Week Tokyo - 6th Bio Pharmaceutical EXPO.

A 3D printer that enables tablet manufacturing using innovative 3D printing technology, revolutionizing personalized medicine.

FabRx, a UK company specializing in pharmaceuticals and biotechnology that spun out from University College London, has launched a 3D printer aimed at the manufacturing of solid dosage forms focused on personalized medicine. The Printlet, a tablet manufactured using a 3D printer with three different nozzles (for powder, gel, and filament), has been tested in various research institutions, hospitals, and pharmacies overseas, and is now available for sale domestically. By using registered formulations and manufacturing conditions in dedicated software, it can be applied in medical settings for personalized medicine, as well as in drug discovery and clinical trial drug manufacturing.

• others

Sterilization applications for biopharmaceuticals and sterile preparations! Filters with high microbial retention, low protein adsorption, and extremely low elution performance.

Advanced Microdevices' sterilizing capsule filter achieves improved throughput through a pre-filter and high flow rates due to low hold-up volume. 【Features】 ■ Improved recovery rate due to low protein adsorption ■ Assurance of microbial capture performance through bacteria challenge testing ■ 100% integrity testing conducted ■ Certificate provided with each filter ■ Compatible with ethylene oxide and autoclave sterilization ■ Gamma radiation sterilization compatible

• Other bio-related products

To reduce contamination risks and streamline the cleaning process.

Single-use assembly tubes for biopharmaceuticals. Tube material, length, connector type, filters, etc. can be customized according to customer requirements. Manufactured in a Class 7 cleanroom. The facility is ISO 13485 and FDA certified. Compatible with gamma sterilization, with various certificates included.

• Filtration Filter

The Nano Dis system can accurately separate nanoparticles from the test solution, enabling consistent and reliable dissolution test results for nano formulations.

The Nano Dis system is a new option that uses conventional dissolution testing equipment. Currently, many new drug candidates are poorly soluble compounds, and improving the solubility of these compounds is important. One attractive solution for improving solubility is nanoparticle formulation. To facilitate the selection of compounds in nanoparticle development, an efficient dissolution testing method is necessary. In the current dissolution testing systems, insufficient filtration of nanoparticles from the test solution leads to variability in test results, resulting in unreliable outcomes. The Agilent NanoDis system addresses these issues and provides researchers with accurate dissolution profiles of active pharmaceutical ingredients through an automated system. This functionality allows researchers to optimize nanoparticle formulations more quickly and bring them to market faster. The automated process yields consistent and reliable dissolution test results for nanoparticle formulations.

• Dissolution Tester
• Other measurement and measuring equipment
• Other Physics and Chemistry Equipment

Corresponds to the Japanese Pharmacopoeia, USP, and EP3. The design minimizes mechanical variation factors of the device using vessels that reduce the deviation of the container's centering.

The dissolution tester 708-DS features one-touch centering with the TruAlign vessel, and its design minimizes the risk of misalignment after installation, reducing the risk of failure during mechanical calibration. It supports Japanese language, has a two-piece paddle, and significantly improves basic operability with an expanded space between the drive unit and the vessel plate. It accommodates a wide range of dosage forms for dissolution testing, including tablets, capsules, rotating cylinders, and the paddle-over-disk method.

• Dissolution Tester

From February 11 (Wednesday) to February 13 (Friday), Mikasa Trading Co., Ltd. will sponsor the technology conference "JANOG57 Meeting in Osaka" held at the Congre Convention Center. This event provides an open platform for field engineers to freely discuss and share the latest network technologies, practical operational know-how, and case studies of failures. This time, we will be exhibiting a booth in collaboration with Western Digital Marketing LLC, showcasing innovative storage solutions such as the "Ultrastar Data60" and HDDs with a maximum capacity of 30TB. The Ultrastar Data60 is recognized for its ability to efficiently accommodate up to 60 high-quality HDDs while achieving large capacity, low cost, and space-saving design. Additionally, we will display mobile label printers made by Brady Japan at our booth. You will have the opportunity to see products that are actively used in infrastructure development and data management up close. Don't miss this chance to experience the technologies that support the future! We look forward to seeing you at the venue.

Cancer Biomarker Discovery 2026 is an online seminar focused on the latest biomarker discovery and analysis technologies in the field of cancer research. Advanced technologies that support the understanding, diagnosis, and treatment research of cancer, such as liquid biopsy, proteomics, and spatial omics analysis, will be introduced. This seminar primarily targets basic and clinical researchers involved in cancer research, as well as those interested in biomarker discovery and analysis. In our section, we will introduce the latest techniques in fluorescent imaging for spatial biology and spatial proteomics research, centered around the Invitrogen EVOS S1000 Spatial Imaging System. Unlike traditional microscopy, which is limited in multiplex immunostaining, our spectral unmixing technology enables simultaneous imaging of up to 9 colors, allowing for rapid data acquisition with minimized sample damage. Additionally, we will explain a practical workflow using direct conjugate antibodies and TSA-based Invitrogen Aluora amplification reagents, proposing high-reproducibility analysis methods that leverage spatial information. For research use only. Not for diagnostic use.

In spatial biology/spatial proteomics research, the coexistence of "high-quality multiplex fluorescence image acquisition" and "reliable quantitative analysis" is becoming increasingly important. This webinar, co-hosted by Thermo Fisher Scientific and Indica Labs, will introduce a practical workflow that allows for a comprehensive understanding from imaging to analysis. Recommended for: - Those interested in spatial biology/spatial proteomics research who want to systematically understand the entire process from imaging to analysis. - Those who are already conducting or considering the implementation of multiplex imaging (multiplex immunostaining). - Those who feel limited by traditional four-color fluorescence observation and wish to engage in higher-dimensional spatial information analysis. This is a free seminar, so please join us. *For research use only. Not for diagnostic use.

[Speaker] Naoki Eguchi, Attorney at Baker McKenzie [Lecture Topics] 1. Utilization of Storage Batteries (1) Storage Batteries for Renewable Energy Integration (2) Grid-Side Storage Batteries (3) Hybrid Power Generation with Solar, Wind, and Storage Batteries 2. Positioning of Grid-Side Storage Batteries 3. Subsidies for Grid-Side Storage Batteries / Long-Term Decarbonization Power Source Auctions 4. Practical Aspects and Contracts for Grid-Side Storage Batteries - Offtake Model, Merchant Model 5. Current Status of Corporate PPAs (Overseas and Japan) 6. Types of Corporate PPAs (Physical and Virtual) 7. Contracts for Corporate PPAs 8. Corporate PPAs and Project Finance 9. Q&A / Business Card Exchange

[Instructor] Professor at Waseda University Graduate School of Political Science and Economics / Director of the Institute for Environmental Economic Management Visiting Researcher at Sciences Po Paris Faculty Fellow at the National Institute of Economic and Industrial Research Mr. Toshihide Arimura [Key Lecture Content] Starting in the fiscal year 2026, participation in the GX-ETS will become mandatory for some companies in Japan. Carbon costs will become an increasingly important factor in considering long-term value creation for businesses. This seminar will explain the impacts of the full-scale implementation of the GX-ETS on Japanese companies and the economy. Additionally, we will introduce the future outlook for the GX-ETS and the paths that should be taken, from the perspectives of comparison with overseas emissions trading systems and its economic significance.